12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marc Riedl, MD MS
UCSD
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Leuven, Belgium
- Facility name not stated
Ottawa, Canada
- Facility name not stated
Grenoble, France
- Facility name not stated
Lille, France
- Facility name not stated
Paris, France
- Facility name not stated
Berlin, Germany
- Facility name not stated
Frankfurt, Germany
- Facility name not stated
Mörfelden-Walldorf, Germany
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Milan, Italy
- Facility name not stated
Birmingham, United Kingdom
- Facility name not stated
Bristol, United Kingdom
- Facility name not stated
Cardiff, United Kingdom
- Facility name not stated
London, United Kingdom
- Facility name not stated
Manchester, United Kingdom
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Scottsdale, Arizona, United States
- Facility name not stated
Granada Hills, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
Walnut Creek, California, United States
- Facility name not stated
Colorado Springs, Colorado, United States
- Facility name not stated
Shreveport, Louisiana, United States
- Facility name not stated
Chevy Chase, Maryland, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Plymouth, Minnesota, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
New York, New York, United States
- Facility name not stated
Charlotte, North Carolina, United States
- Facility name not stated
Cincinnati, Ohio, United States
- Facility name not stated
Oklahoma City, Oklahoma, United States
- Facility name not stated
Tulsa, Oklahoma, United States
- Facility name not stated
Lake Oswego, Oregon, United States
- Facility name not stated
Hershey, Pennsylvania, United States
- Facility name not stated
Pittsburgh, Pennsylvania, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
Galveston, Texas, United States
- Facility name not stated
Fairfax, Virginia, United States
- Facility name not stated
Spokane, Washington, United States
- Facility name not stated
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Dec 2014
- Primary completion
- 31 Jan 2016
- Completion
- 31 Jan 2016
- Last update posted
- 17 Nov 2025
- Registered enrollment
- 110
- Registry id
- NCT02303626
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.